35 results
425
SPRC
SciSparc Ltd
12 Apr 24
Business combination disclosure
9:23am
. Since the date of its incorporation, Merger Sub has not engaged in any activities other than activities incident to its formation or in connection
6-K
EX-99.1
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
, Merger Sub has not engaged in any activities other than activities incident to its formation or in connection with or as contemplated
F-1
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
will pay the expenses incident to the registration under the Securities Act of the offer and sale of the Ordinary Shares covered by this prospectus
6-K
EX-10.1
SPRC
SciSparc Ltd
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
expenses incident to the performance of its obligations hereunder, including but not limited to (i) the preparation, printing and filing
F-3/A
SPRC
SciSparc Ltd
20 Nov 23
Shelf registration (foreign) (amended)
4:22pm
or indirectly, with any person to distribute the securities.
We are required to pay certain fees and expenses incurred by us incident
F-3
486kqojeuz1qkd
3 Nov 23
Shelf registration (foreign)
4:06pm
6-K
EX-1.1
88l14h2wkog
14 Aug 23
SciSparc Ltd. Announces Pricing of $1.3 Million Underwritten Public Offering
4:31pm
6-K
EX-99.1
yhf12ag95
16 May 23
At-The-Market Issuance Sales Agreement
8:06pm
6-K
EX-99.1
525e1s71 ri7ndb2l
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
EX-99.2
zzoppmdm3uoy0 uk
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
EX-99.3
aw5vw39 de0nxod8yt
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
F-3
0fj3kuq7qcl2l6cc6y
7 Jul 22
Shelf registration (foreign)
4:22pm
6-K
EX-99.2
fbp1r
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
6-K
EX-99.3
b7vdf6pnvx 0pd19
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
POS AM
jle29s
8 Oct 21
Prospectus update (post-effective amendment)
12:00am
F-1/A
eolpk
28 Apr 21
Registration statement (foreign) (amended)
4:38pm
F-1
b77mklu0ob59
21 Apr 21
Registration statement (foreign)
4:17pm
6-K
EX-99.2
pjrl1d
2 Mar 21
Report of Foreign Private Issuer
4:05pm
6-K
EX-99.3
mad 2rvjn3h6nzs
2 Mar 21
Report of Foreign Private Issuer
4:05pm
6-K
EX-1.1
5q19o
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm